Skip to main content
. 2021 Jul 2;10(13):e022125. doi: 10.1161/JAHA.121.022125

Figure 5. Antithrombotic drugs currently developed for the treatment of acute coronary syndrome.

Figure 5

GP indicates glycoprotein; PAR, protease‐activated receptors; and PDI, protein disulfide isomerase.